Dilaudid, or hydromorphone, stands out in the realm of pain management due to its high potency and effectiveness in treating severe pain. It is classified as a Schedule II controlled substance, reflecting its potential for abuse and addiction. This classification necessitates stringent prescribing practices and careful patient selection to ensure that its benefits outweigh the risks.
